Enzon Pharmaceuticals, Inc. (OTCMKTS:ENZN – Get Free Report) was the target of a significant decrease in short interest in the month of September. As of September 30th, there was short interest totalling 1,600 shares, a decrease of 33.3% from the September 15th total of 2,400 shares. Based on an average daily volume of 27,300 shares, the short-interest ratio is presently 0.1 days.
Enzon Pharmaceuticals Price Performance
Shares of ENZN traded down $0.01 during mid-day trading on Monday, reaching $0.11. 14,996 shares of the company’s stock traded hands, compared to its average volume of 24,505. The stock has a market cap of $8.16 million, a P/E ratio of 11.00 and a beta of 0.48. The stock’s 50-day moving average is $0.14 and its two-hundred day moving average is $0.13. Enzon Pharmaceuticals has a 12 month low of $0.06 and a 12 month high of $0.24.
About Enzon Pharmaceuticals
Read More
- Five stocks we like better than Enzon Pharmaceuticals
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Whirlpool’s High Dividend Yield Is Too Good to Pass Up
- The 3 Best Blue-Chip Stocks to Buy Now
- Holiday Spending Boom Ahead: 3 BNPL Stocks Poised for Gains
- The Role Economic Reports Play in a Successful Investment Strategy
- Boeing: A Perfect Storm of Trouble Is a Loaded Buying Opportunity
Receive News & Ratings for Enzon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enzon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.